Biotech

All Articles

' All hands on deck' at Lilly as peers target obesity market

.CEO David Ricks can easily view the providers setting up camping tents at basecamp behind Eli Lilly...

Entero laying off team, abandoning office and pausing R&ampD

.Bed mattress Liquidators has switched Entero Therapeutics white as a slab. The creditor purchased E...

Exelixis drops ADC after determining it's no match for Tivdak

.Exelixis is quiting on its tissue element (TF)- targeting antibody-drug conjugate after concluding ...

Relay dislikes SHP2 inhibitor after Genentech leaves behind

.3 weeks after Roche's Genentech unit ignored an SHP2 prevention pact, Relay Rehab has actually vali...

Stoke's Dravet disorder med released of partial medical hold

.Stoke Therapies' Dravet disorder medication has been without a partial hold, removing the way for t...

Fierce Biotech's Gabrielle Masson provides Strong 15 at NYSE

.Intense Biotech Colleague Publisher Gabrielle Masson presented the 2024 class of Strong 15 champion...

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH possibility

.Novo Nordisk has axed its own once-monthly twin GLP-1/ GIP receptor agonist, ending (PDF) developme...

Daiichi pays for Merck $170M to create bronchi cancer cells T-cell engager deal

.Merck &amp Co. has swiftly recouped several of the costs of its own Javelin Therapies buyout, pulli...

BioMarin standstills preclinical genetics treatment for heart condition

.After BioMarin carried out a spring well-maintained of its own pipeline in April, the company has a...

Eisai plants molecular glue SEED along with $1.5 B biobucks deal

.Big Pharmas continue to be caught to the concept of molecular adhesive degraders. The latest firm t...